Miguel Caballero‐Baños

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

Valentín Ortiz‐Maldonado, Susana Rives, María Castellà et al. · Molecular Therapy · 2020 · 151 citations · Full text

Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial

María Castellà, Miguel Caballero‐Baños, Valentín Ortiz‐Maldonado et al. · Frontiers in Immunology · 2020 · 132 citations · Full text

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions

María Castellà, Anna Boronat, Raquel Martín‐Ibáñez et al. · Molecular Therapy — Methods & Clinical Development · 2018 · 122 citations · Full text

Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients

Miguel Caballero‐Baños, Daniel Benítez‐Ribas, Jaime Tabera et al. · European Journal of Cancer · 2016 · 57 citations

Surgical Oncology, Oncology, Phase Ii +6

Modulation of CD6 function through interaction with Galectin‐1 and ‐3

Cristina Escoda-Ferran, Esther Carrasco, Miguel Caballero‐Baños et al. · FEBS Letters · 2014 · 27 citations · Full text